Carsten Mainitz
The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.
Most recently, he headed a Hamburg-based investment research company as a member of the board for 8 years.
He is particularly interested in international small and micro caps and empirical capital market research (behavioral finance).
Commented by Carsten Mainitz
Commented by Carsten Mainitz on October 16th, 2025 | 07:25 CEST
Europe is building a drone wall – Manufacturers like Volatus Aerospace set to benefit enormously!
The world is arming up. NATO has decided to invest 5% of its GDP annually in defense and security-related infrastructure from 2035 onwards! This means that more than EUR 300 billion per year will be spent. Large sums will flow into air defense, cyber defense, AI, and drone defense. The increasing number of airspace violations, presumably by Russian drones, is demanding action not only from the affected Eastern European countries but also from the entire NATO alliance. Which companies are on the winning side?
Read
Commented by Carsten Mainitz on October 15th, 2025 | 08:25 CEST
If you are looking for outperformance, you will find it here: Nakiki, Strategy, Palantir!
Cryptocurrencies are currently still digesting the latest flash crash, which briefly sent the BTC price from its all-time high of over USD 126,000 down to USD 107,000. It has now stabilized around USD 110,000. For investors, corrections in an intact upward trend are always excellent opportunities to build or expand positions. US investment bank JPMorgan is forecasting prices of USD 165,000 for Bitcoin this year. Sounds like a very high return? Yes, but it gets even better: Strategy has already shown the way. So-called BTC treasury strategies are outperforming cryptocurrencies. We take a closer look at the strategy and the exciting, promising newcomer, Nakiki SE.
Read
Commented by Carsten Mainitz on October 14th, 2025 | 07:15 CEST
Momentum plays with a new wave: Almonty Industries and Rheinmetall – what is Gerresheimer doing?
The trade dispute between the US and China appears to be entering the next round. Late last week, US President Trump announced his intention to impose additional punitive tariffs of 100% on Chinese goods. The measures are expected to take effect by November at the latest. This follows China's decision to tighten export controls on certain technologies and raw materials. China holds many critical raw materials and is gradually restricting their export. While consumers face major challenges in view of the shortage of demand and rising prices, producers of these raw materials are among the stock market favorites.
Read
Commented by Carsten Mainitz on October 9th, 2025 | 07:35 CEST
BioNxt Solutions, Bayer, Evotec – Enormous upside! The interface of biotech and pharmaceuticals!
The global rise in lifestyle diseases such as diabetes, obesity, multiple sclerosis (MS), and MASH (metabolic fatty liver disease) is driving enormous growth in the healthcare sector. The market for cancer therapies is also expanding rapidly. Meanwhile, the M&A landscape is developing dynamically: large pharmaceutical companies need to act as patent protections expire, securing their pipeline through acquisitions and partnerships. Areas offering innovative drugs or novel delivery methods are especially attractive. This is where a promising second-tier stock comes into play.
Read
Commented by Carsten Mainitz on October 8th, 2025 | 07:25 CEST
Desert Gold, Barrick Mining, Nel ASA – Do not miss out: Favorites are changing in the bull market!
The stock markets are celebrating record highs. Many major indices are approaching—or have already surpassed—their all-time highs. Meanwhile, the price of gold is trading at around USD 4,000 per ounce, a historic level. Investors are closely watching the US Federal Reserve, as further interest rate cuts seem likely, providing additional tailwind for the markets. But as is often the case with upward trends, a change in favorites could be imminent. Here are some stocks that could soon accelerate into the fast lane.
Read
Commented by Carsten Mainitz on October 7th, 2025 | 07:45 CEST
Aspermont, Palantir, RENK – AI sets the pace. Where is the next run?
International stock markets are booming. The Dow Jones recently surpassed 47,000 points, seemingly unaffected by the US government shutdown. The topic of artificial intelligence (AI) continues to be the focus of investor interest, and recent company announcements are causing a stir. Japanese electronics giant Hitachi and ChatGPT provider OpenAI are partnering to build AI infrastructure and global data centers. Meanwhile, Fujitsu and leading AI chip manufacturer Nvidia are expanding their collaboration and plan to jointly develop a platform that uses AI in a targeted manner for specific industries, such as healthcare and robotics. In view of the AI boom, it is becoming increasingly compelling to explore second- and third-tier stocks that could benefit from the surge in innovation and investor interest.
Read
Commented by Carsten Mainitz on October 2nd, 2025 | 07:10 CEST
NetraMark Holdings, Evotec, Sartorius – Billion-dollar deals in sight!
Artificial intelligence and machine learning have become key drivers across nearly every industry. When pharmaceutical companies successfully develop a drug to market readiness, profits can surge. However, only a few active ingredients that enter clinical trials ultimately receive approval. It is therefore a long, risky, and costly process. The use of AI can help to minimize these risks significantly. Here, we take a look at the potential of AI-based strategies among established players Evotec and Sartorius, with a particular focus on the innovative approach of Canadian company NetraMark Holdings.
Read
Commented by Carsten Mainitz on October 1st, 2025 | 07:05 CEST
Almonty Industries, Gerresheimer, BASF – It is not too late yet!
The race for critical high-tech goods and raw materials is already underway. The COVID-19 pandemic painfully highlighted the downsides of a globally interconnected economy. China's export ban on critical raw materials is currently having a double impact, as the country dominates the market. This effect is expected to continue to intensify in the future as demand continues to rise dynamically while supply increases only slowly. This provides a strong tailwind for raw material producers, but poses significant challenges for companies in other sectors.
Read
Commented by Carsten Mainitz on September 30th, 2025 | 07:40 CEST
Antimony Resources, Rheinmetall, Novo Nordisk – Something is in the air!
Sufficient access to raw materials is crucial for any economy. The EU has compiled a list of 34 critical raw materials. How critical a raw material is classified depends on two parameters: "economic importance" and "supply risk." This list also includes a little-known but very important metalloid – antimony. The price of antimony skyrocketed at the end of 2024 in the wake of China's export ban. There are still exciting investment opportunities in this area.
Read
Commented by Carsten Mainitz on September 26th, 2025 | 07:35 CEST
Gerresheimer, dynaCERT, Volkswagen – Exciting developments!
News drives prices. However, the pendulum can swing in both directions. For informed investors, the correct interpretation of events is crucial. Often, this then leads to lucrative entry and exit signals. Gerresheimer was the latest to be hit, but which stock could be next? However, there are also stocks that are due for a realignment, offering opportunities for rising prices.
Read